drugset / Trial / NCT03250923
CelAgace™ OraRinse Solution for Treatment of Candidiasis
NaSingle-groupOpen-labelTreatment
Summary
CelAgace™ OraRinse (silver citrate complex and acemannan) Solution is planned to be evaluated for safety and effectiveness as a potential treatment for candidiasis, a yeast infection, commonly known as thrush, which is associated with mouth sores.
Timeline
- Start
- 2024-09
- Primary completion
- 2024-09
- Completion
- 2025-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | acemannan | Other / unclassified | 40 mg | Oral |
| Subject | silver citrate complex | Other / unclassified | 100 ug | Oral |